Severe hypoglycemia induced by tramadol: Two new cases of an unlisted side effect;Hypoglycémies sévères au tramadol deux nouvelles observations d'un effet indésirable non référencé

Revue de Medecine Interne

Volumn 32, Issue 11, 2011, Pages 703-705

  Taugourdeau, S ^a   Chiche, L ^b   Rouby, F ^a   Default, A ^a   Boyer, M ^a   Castellan, D ^a   Lanfranchi, M A ^b   Bornet, C ^b   Jean, R ^a   Harle J R ^a   Durand, J M ^a   Jean Pastor, M J ^b  

^a ASSISTANCE PUBLIQUE HÔPITAUX DE MARSEILLE   (France)

^b HÔPITAL DE LA CONCEPTION   (France)

Author keywords

Adverse effects; Hypoglycemia; Tramadol

Indexed keywords

TRAMADOL;

ARTICLE; CASE REPORT; CLINICAL FEATURE; DISEASE SEVERITY; DRUG INDUCED DISEASE; HUMAN; HYPOGLYCEMIA;

ADVERSE DRUG REACTION REPORTING SYSTEMS; AGED, 80 AND OVER; ANALGESICS, OPIOID; FEMALE; HUMANS; HYPOGLYCEMIA; MALE; PAIN; PHARMACOVIGILANCE; SEVERITY OF ILLNESS INDEX; TRAMADOL;

EID: 82455164200     PISSN: 02488663     EISSN: 17683122     Source Type: Journal    
DOI: 10.1016/j.revmed.2011.06.005     Document Type: Article

References (23)

1. Houlihan D.J. Serotonin syndrome resulting from coadministration of tramadol, venlafaxine, and mirtazapine. Ann Pharmacother 2004, 38:411-413.
2. Grandvuillemin A., Jolimoy G., Authier F., Dautriche A., Duhoux F., Sgro C. Hypoglycémie lors d'un traitement par tramadol. À propos de deux cas. Presse Med 2006, 35:1842-1844.
3. Jonville-Bera A.P., Marie A., Magba D., Gedon E., Autret-Leca E. Hypoglycémie associée au tramadol chez un diabétique. Therapie 2010, 65:499-500.
4. Peyriere H., Villiet M., Alibert V., et al. Hypoglycemia related to tramadol therapy. Analysis of cases reported to the French pharmacovigilance database. Fundam Clin Pharmacol 2004, 18:215.
5. Vial T., Gouraud A., Auriche P., Daveluy A., Rocher F., Hillaire-Buys D., et al. Tramadol-induced hypoglycemia: a comparison with other step 2 analgesic drugs. Fundam Clin Pharmacol 2011, 25:110.
6. Derijks H.J., Heerdink E.R., De Koning F.H., Janknegt R., Klungel O.H., Egberts A.C. The association between antidepressant use and hypoglycaemia in diabetic patients: a nested case-control study. Pharmacoepidemiol Drug Saf 2008, 17:336-344.
7. Derijks H.J., Meyboom R.H., Heerdink E.R., De Koning F.H., Janknegt R., Lindquist M., et al. The association between antidepressant use and disturbances in glucose homeostasis: evidence from spontaneous reports. Eur J Clin Pharmacol 2008, 64:531-538.
8. Chi T.C., Ho Y.J., Chen W.P., Chi T.L., Lee S.S., Cheng J.T., et al. Serotonin enhances β-endorphin secretion to lower plasma glucose in streptozotocin-induced diabetic rats. Life Sci 2007, 80:1832-1838.
9. Hwang S.L., Liu I.M., Cheng J.T. Activation of imidazoline receptors in adrenal gland to lower plasma glucose in streptozocin-induced diabetic rats. Diabetologia 2005, 48:767-775.
10. Sanders N.M., Wilkinson C.W., Taborsky G.J., Al-Noori S., Daumen W., Zavosh A., et al. The selective serotonin reuptake inhibitor sertraline enhances counterregulatory responses to hypoglycemia. Am J Physiol Endocrinol Metab 2008, 294:E853-E860.
11. Yamada J., Sugimoto Y., Kimura I., Takeuchi N., Horisaka K. Serotonin-induced hypoglycemia and increased serum insulin levels in mice. Life Sci 1989, 45:1931-1936.
12. Yamada J., Sugimoto Y., Inoue K. Selective serotonin reuptake inhibitors fluoxetine and fluvoxamine induce hyperglycemia by different mechanism. Eur J Pharmacol 1999, 382:211.
13. Brase D.A., Ward C.R., Tripathi H.L., Dewey W.L. An insulin-independent mechanism of intrathecal morphin-induced hypoglycemia in mice: mediation through a central alpha-2 adrenergic pathway. J Pharmacol Exp Ther 1991, 257:587-594.
14. Radosevich P.M., Williams P.E., Lacy D.B., McRae J.R., Steiner K.E., Cherrington A.D., et al. Effect of morphine on glucose homeostasis in the conscious dog. J Clin Invest 1984, 74:1473-1480.
15. Cheng J.T., Liu I.M., Tzeng T.F., Lu F.H., Chang C.J. Plasma glucose-lowering effect of tramadol in streptozotocin-induced diabetic rats. Diabetes 2001, 50:2815-2821.
16. Tzeng T.F., Liu I.M., Lai T.Y., Tsai C.C., Chang W.C., Cheng J.T. Loperamide increases glucose utilization in streptozotocin-induced diabetic rats. Clin Exp Pharmacol Physiol 2003, 30:734-738.
17. Liu I.M., Chi T.C., Chen Y.C., Lu F.H., Chenq J.T. Activation of opioid mu-receptor by loperamide to lower plasma glucose in streptozotocin-induced diabetic rats. Neurosci Lett 1999, 265:183-186.
18. Lee H.T., Tseng W.C., Tarng D.C. Recurent hypoglycemia in a hemodialysis patient related to propoxyphene treatement. J Chin Med Assoc 2007, 70:286-288.
19. Wiederholt I.C., Genco M., Foley J.M. Recurrent episodes of hypoglycemia induced by propoxyphene. Neurology 1967, 17:703-706.
20. Almirall J., Montoliu J., Torras A., Revert L. Propoxyphene-induced hypoglycemia in a patient with chronic renal failure. Nephron 1989, 53:273-275.
21. Shah P., Aniszweski J., Service F.J. Propoxyphene-induced hypoglycemia in renal failure. Endocr Pract 2006, 12:170-173.
22. Gaubert S., Vié M., Damase-Michel C., Pathak A., Montastruc J.L. Dextropropoxyphene withdrawal from a French university hospital: impact on analgesic drug consumption. Fundam Clin Pharmacol 2009, 23:247-252.
23. Agence française de sécurité sanitaire des produits de santé. Mise au point prise en charge des douleurs de l'adulte modérées à intenses. 2010 ; Disponible sur http://www.afssaps.fr/Infos-de-securite/Mises-au-point/Prise-en-charge-des-douleurs-de-l-adulte-moderees-a-intenses-Mise-au-point/(language)/fre-FR.